Tag archive
June 2026: New tattoo ink toxicology data reshapes REACH compliance. Studio owners must verify pigment documentation and update consent forms.
Three REACH restrictions sit in ECHA's 2026 opinion queue: PFAS, chromium(VI) and octocrylene. What body art supply chains must document, and when.
Polymer science and flexible body jewelry materials by Patrick Poli.
How long can you wear BioFlex®? Its creator answers: it is engineered for continuous long-term wear. Why the "porous plastic" warning describes acryli
Under 5 percent of bloodborne disease is reliably attributed to tattooing, yet meta-analyses find raised HCV, HBV and HIV in tattooed people. Venue re
Recent clinical and industry data show that medical elastomers are only truly “medical grade” when backed by ISO 10993 testing, with BioFlex® and Biop
EU tattoo-ink compliance still turns on REACH Annex XVII, label claims, and batch traceability. FDA contamination alerts show why studios need stronge
Clearer ISO 10993 rules and new data on silicone, TPU, PTFE, and PP‑R mean studios must treat “medical elastomers” as distinct chemistries, not interc
US tattoo ink regulation is coming. The 2026 policy agenda, MoCRA gaps, and bioaccessibility data show what studios must demand from ink suppliers now
BioFlex(R) and Bioplast are PP-R, not TPU, so flexible jewelry buying starts with resin chemistry, not marketing labels.
Discover how hydrogels, nanocomposites, and programmable polymers are transforming body jewelry beyond PHA. Stay ahead with next-gen material insights
ECHA added n-hexane and BPAF to the SVHC Candidate List on Feb 4, 2026 (253 substances). What body art studios must know, and why BioFlex is unaffecte